Cannabis M&A Heats Up as DEA Maps the Next Federal Framework

Curaleaf cleared a key hurdle in its pursuit of Aurora Cannabis, while the DEA signaled that separate production limits are coming for Schedule III marijuana. In Los Angeles, authorities are investigating a deadly crash outside the North Hollywood Metro station.

DEA Narrows Cannabis Fight as Skydance Draws Musk Capital

A DEA judge rejected an attempt to reopen the marijuana rescheduling hearing, while federal prosecutors charged a senior Virginia lawmaker in an alleged cannabis distribution enterprise. In media finance, Elon Musk reportedly invested roughly $1 billion in the newly enlarged Skydance.

Rescheduling Stalls as Cronos Expands and Netflix Changes Course

Federal marijuana rescheduling faces another procedural delay while Cronos Group establishes a major position in Europe’s regulated adult-use market. In entertainment, Netflix is installing veteran executive Peter Rice atop its global content operation.

Cannabis Court Fight Advances as Bedrocan Enters Bankruptcy

Federal cannabis opponents and the Justice Department proposed a timetable for a major rescheduling lawsuit, while the Netherlands’ sole medical cannabis supplier entered bankruptcy. Netflix is also reportedly preparing its largest workforce reduction since 2022.

Alabama Clears Cannabis Shift as TerrAscend Battles Tax Clawback

Alabama removed a state-level obstacle to federal marijuana rescheduling, while TerrAscend challenged the government’s effort to recover an $8.36 million tax refund. In Los Angeles, new restitution laws are being tested through lawsuits involving artworks held by the Norton Simon Museum and the Auschwitz Memorial.